Thiard News@F4F

@newsen.bsky.social

9 months ago

Pomerantz Law Firm Files Class Action Against UroGen Pharma for Investors with Losses Investors suffering losses in UroGen Pharma are urged to join a class action lawsuit. Key deadlines and details are provided for potential plaintiffs.

Pomerantz Law Firm Files Class Action Against UroGen Pharma for Investors with Losses #United_States #New_York #Securities_Fraud #Pomerantz_LLP #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Investors Encouraged to Participate in Class Action Lawsuit Bronstein, Gewirtz & Grossman LLC informs UroGen Pharma investors about a class action lawsuit aimed at recovering losses incurred between July 2023 and May 2025.

UroGen Pharma Investors Encouraged to Participate in Class Action Lawsuit #United_States #New_York #Class_Action #Bronstein_Gewirtz #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investigation Launched by Pomerantz Law Firm for UroGen Pharma Investors' Claims Pomerantz Law Firm is conducting an investigation into potential securities fraud involving UroGen Pharma Ltd., after FDA concerns about its bladder cancer drug led to a significant drop in stock price.

Investigation Launched by Pomerantz Law Firm for UroGen Pharma Investors' Claims #United_States #New_York #Class_Action #UroGen_Pharma #FDA_concerns

Thiard News@F4F

@newsen.bsky.social

9 months ago

Pomerantz Law Firm Launches Investigation into UroGen Pharma's Investor Claims Pomerantz Law Firm is probing claims on behalf of UroGen Pharma Ltd. investors, highlighting potential securities fraud and misleading practices.

Pomerantz Law Firm Launches Investigation into UroGen Pharma's Investor Claims #United_States #New_York #Pomerantz_LLP #Investor_Claims #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

Pomerantz Law Firm Examines Potential Securities Fraud at UroGen Pharma Ltd. Pomerantz Law Firm is investigating claims related to potential securities fraud involving UroGen Pharma Ltd and its bladder cancer drug UGN-102, following alarming FDA feedback.

Pomerantz Law Firm Examines Potential Securities Fraud at UroGen Pharma Ltd. #USA #New_York #Pomerantz_Law #UroGen_Pharma #UGN-102

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Investors Invited to Join Securities Fraud Class Action Lawsuit UroGen Pharma Ltd. investors can take action against alleged securities fraud in a class action lawsuit. Lead by the Schall Law Firm, this initiative seeks accountability for misleading company statements.

UroGen Pharma Investors Invited to Join Securities Fraud Class Action Lawsuit #United_States #Los_Angeles #Schall_Law_Firm #securities_lawsuit #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Ltd. Faces Class Action: Key Deadlines and Implications for Investors UroGen Pharma Ltd. is currently involved in a class action lawsuit. Shareholders must register by July 28, 2025, to be eligible for potential recovery.

UroGen Pharma Ltd. Faces Class Action: Key Deadlines and Implications for Investors #USA #New_York #Class_Action #UroGen_Pharma #URGN

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investors Rally Against UroGen Pharma Following Securities Fraud Allegations in Major Class Action Lawsuit UroGen Pharma Ltd. faces a significant class action lawsuit for alleged securities violations. Investors are urged to seek representation by Levi & Korsinsky before the July 2025 deadline.

Investors Rally Against UroGen Pharma Following Securities Fraud Allegations in Major Class Action Lawsuit #United_States #New_York #Securities_Law #UroGen_Pharma #URGN

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Ltd. Shareholders Can Lead Class Action Against Company Following Major Stock Losses UroGen Pharma Ltd. investors who faced significant losses may now lead a class action lawsuit as they seek justice against the company's alleged misrepresentation.

UroGen Pharma Ltd. Shareholders Can Lead Class Action Against Company Following Major Stock Losses #United_States #San_Diego #Class_Action #UroGen_Pharma #URGN_stocks

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investors May Lead Class Action Against UroGen Pharma for Securities Fraud Claims A class action lawsuit against UroGen Pharma Ltd. is open for investors who purchased securities from July 2023 to May 2025. Act now for potential compensation.

Investors May Lead Class Action Against UroGen Pharma for Securities Fraud Claims #United_States #New_York #Securities_Fraud #Rosen_Law_Firm #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

Faruqi & Faruqi Initiates Investigation on UroGen Pharma Investors Claims Faruqi & Faruqi, LLP is probing claims related to UroGen Pharma Ltd., urging investors who lost money between July 2023 and May 2025 to come forward.

Faruqi & Faruqi Initiates Investigation on UroGen Pharma Investors Claims #United_States #New_York #Securities_Law #Faruqi_&_Faruqi #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Ltd. Shareholders: Important Class Action Lawsuit Updates UroGen Pharma investors have a chance for recovery through a class action lawsuit led by Levi & Korsinsky. Learn how to participate.

UroGen Pharma Ltd. Shareholders: Important Class Action Lawsuit Updates #United_States #New_York #Class_Action #Levi_&_Korsinsky #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Investors Take Action: Opportunity to Join Class Action Lawsuit Investors of UroGen Pharma Ltd. facing significant losses can now participate in a securities fraud class action lawsuit led by The Law Offices of Howard G. Smith before the upcoming deadline.

UroGen Pharma Investors Take Action: Opportunity to Join Class Action Lawsuit #USA #Class_Action #Securities_Fraud #Bensalem #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Ltd. Investors Urged to Join Securities Fraud Class Action Lawsuit Investors impacted by UroGen Pharma Ltd.'s misleading statements are encouraged to join a class action lawsuit to reclaim losses with the Schall Law Firm.

UroGen Pharma Ltd. Investors Urged to Join Securities Fraud Class Action Lawsuit #United_States #Los_Angeles #Schall_Law_Firm #UroGen_Pharma #U.S._Securities

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Ltd. Faces Class Action Lawsuit; Shareholder Participation Urged A class action lawsuit has been filed against UroGen Pharma Ltd. urging shareholders who purchased during the specified period to participate by the July 28, 2025, deadline.

UroGen Pharma Ltd. Faces Class Action Lawsuit; Shareholder Participation Urged #United_States #New_York #Class_Action #Gross_Law_Firm #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investors in UroGen Pharma are Under Investigation for Possible Securities Fraud Pomerantz Law Firm is investigating claims regarding potential securities fraud involving UroGen Pharma, amid significant stock price decline following FDA scrutiny.

Investors in UroGen Pharma are Under Investigation for Possible Securities Fraud #United_States #New_York #Pomerantz_Law_Firm #UroGen_Pharma #URGN

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Ltd. Investors: Join the Class Action Lawsuit Now! Investors in UroGen Pharma Ltd. facing substantial losses are invited to participate in a pivotal class action lawsuit. Don't miss the deadline!

UroGen Pharma Ltd. Investors: Join the Class Action Lawsuit Now! #United_States #Robbins_Geller #San_Diego #Class_Action #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

Opportunity for UroGen Pharma Investors to Lead Securities Fraud Lawsuit Against Company UroGen Pharma investors with losses have a chance to lead a class action lawsuit regarding alleged securities fraud, with the deadline approaching soon.

Opportunity for UroGen Pharma Investors to Lead Securities Fraud Lawsuit Against Company #USA #Class_Action #Los_Angeles #Securities_Fraud #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Investors Urged to Join Class Action Lawsuit for Potential Recovery An urgent call for UroGen Pharma Ltd. investors to join a class action lawsuit has been issued. If you lost money, find out more about your rights and potential compensation.

UroGen Pharma Investors Urged to Join Class Action Lawsuit for Potential Recovery #United_States #New_York #Class_Action #Securities_Fraud #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Investors Can Seize Opportunity in Class Action Lawsuit Investors in UroGen Pharma have a chance to join a class action lawsuit for potential compensation after securities fraud allegations. Learn more.

UroGen Pharma Investors Can Seize Opportunity in Class Action Lawsuit #United_States #New_York #Securities_Fraud #Rosen_Law_Firm #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

UroGen Pharma Ltd. Faces Class Action Following FDA's Preliminary Findings Against UGN-102 UroGen Pharma Ltd. is embroiled in a securities class action due to the FDA's alarming briefing that jeopardized UGN-102's approval. Investors are urged to act.

UroGen Pharma Ltd. Faces Class Action Following FDA's Preliminary Findings Against UGN-102 #United_States #San_Francisco #Hagens_Berman #UroGen_Pharma #UGN-102

Thiard News@F4F

@newsen.bsky.social

9 months ago

The Gross Law Firm Informs UroGen Pharma Investors of Class Action and Important Deadlines UroGen Pharma Ltd. investors are notified of a new class action lawsuit by The Gross Law Firm with a critical registration deadline approaching.

The Gross Law Firm Informs UroGen Pharma Investors of Class Action and Important Deadlines #USA #New_York #Class_Action #Gross_Law_Firm #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

9 months ago

Faruqi & Faruqi, LLP Investigates Claims Against UroGen Pharma for Investors Faruqi & Faruqi, LLP is looking into potential securities claims on behalf of UroGen Pharma Ltd. investors who faced significant losses.

Faruqi & Faruqi, LLP Investigates Claims Against UroGen Pharma for Investors #United_States #New_York #Faruqi_&_Faruqi #UroGen_Pharma #UGN-102

Thiard News@F4F

@newsen.bsky.social

10 months ago

UroGen Pharma Ltd. Investors Encouraged to Join a Class Action Lawsuit Led by Schall Law Firm The Schall Law Firm invites UroGen Pharma investors to participate in a securities fraud class action. Shareholders can claim their losses before the deadline.

UroGen Pharma Ltd. Investors Encouraged to Join a Class Action Lawsuit Led by Schall Law Firm #United_States #Class_Action #Los_Angeles #Schall_Law_Firm #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

10 months ago

Opportunities for UroGen Pharma Investors to Lead Class Action Lawsuit Amid Substantial Losses Investors in UroGen Pharma with significant losses may now lead a class action lawsuit against the company. The case centers around alleged misrepresentations affecting stock value.

Opportunities for UroGen Pharma Investors to Lead Class Action Lawsuit Amid Substantial Losses #United_States #San_Diego #Class_Action #Securities_Fraud #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

10 months ago

Pomerantz Law Firm Launches Investigation into UroGen Pharma Ltd. Investors' Claims Pomerantz LLP is actively investigating potential securities fraud claims for investors of UroGen Pharma Ltd. amid significant stock price drops and FDA concerns.

Pomerantz Law Firm Launches Investigation into UroGen Pharma Ltd. Investors' Claims #United_States #New_York #Securities_Fraud #Pomerantz_LLP #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

10 months ago

Legal Alert: UroGen Pharma Investors Now Have Class Action Opportunities Faruqi & Faruqi reveals major opportunities for UroGen Pharma investors who suffered significant losses. Navigate your legal rights now!

Legal Alert: UroGen Pharma Investors Now Have Class Action Opportunities #USA #New_York #Securities_Fraud #Faruqi_&_Faruqi #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

10 months ago

Robbins LLP Informs Investors of UroGen Pharma Class Action Lawsuit Developments This article discusses the class action lawsuit against UroGen Pharma Ltd. regarding their failed drug trial for UGN-102, detailing investor impacts and allegations.

Robbins LLP Informs Investors of UroGen Pharma Class Action Lawsuit Developments #United_States #San_Diego #Class_Action #Robbins_LLP #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

10 months ago

UroGen Pharma Investors Seize Opportunity for Class Action Lawsuit Amidst Stock Decline Investors in UroGen Pharma Ltd. can now lead a class action lawsuit for substantial losses incurred due to misleading statements about drug studies.

UroGen Pharma Investors Seize Opportunity for Class Action Lawsuit Amidst Stock Decline #United_States #San_Diego #Class_Action #U.S._FDA #UroGen_Pharma

Thiard News@F4F

@newsen.bsky.social

10 months ago

UroGen Pharma Shares Plunge After FDA Advisory Committee Rejects UGN-102 Treatment UroGen Pharma Ltd. faces serious losses as shares drop 44% following a negative FDA committee vote on UGN-102, raising investor concerns.

UroGen Pharma Shares Plunge After FDA Advisory Committee Rejects UGN-102 Treatment #United_States #San_Francisco #UroGen_Pharma #UGN-102 #FDA_Advisory